Inhibition of Borna disease virus-mediated cell fusion by monoclonal antibodies directed against the viral glycoprotein

Intervirology

Volumn 47, Issue 2, 2004, Pages 108-113

  Furrer, Esther ^a   Planz, Oliver ^a   Stitz, Lothar ^a,b  

^a Institut fur Immunologie   (Germany)

^b Bfa F Viruskrankheiten der Tiere   (Germany)

Author keywords

Borna disease virus; Cell fusion; Glycoprotein; Monoclonal antibody

Indexed keywords

FURIN; MONOCLONAL ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BORNA DISEASE VIRUS; CARBOXY TERMINAL SEQUENCE; CELL FUSION; CONTROLLED STUDY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; VACCINIA VIRUS; VERO CELL; VIRUS EXPRESSION; VIRUS INHIBITION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BORNA DISEASE VIRUS; CELL FUSION; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; EPITOPES; MOLECULAR WEIGHT; VERO CELLS; VIRAL FUSION PROTEINS;

BORNA DISEASE VIRUS; VACCINIA VIRUS;

EID: 3042638662     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077834     Document Type: Article

References (34)

1. Rott R, Becht H: Natural and experimental Borna disease in animals. Curr Top Microbiol Immunol 1995;190:17-30.
2. Stitz L, Rott R: Borna disease virus; in Webster RG, Granoff A (eds): Encyclopedia of Virology. New York, Academic, 1999, pp 167-173.
3. Narayan O, Herzog S, Frese K, Scheefers K, Rott R: Pathogenesis of Borna disease in rats: Immune-mediated viral ophthalmoencephalopathy causing blindness and behavioral abnormalities. J Infect Dis 1983;148:305-315.
4. Hirano N, Kao M, Ludwig H: Persistent, tolerant or subacute infection in Borna disease virus infected rats. J Gen Virol 1983;64:1521-1530.
5. Briese T, Schneemann A, Lewis AJ, Park YS, Kim S, Ludwig H, Lipkin WI: Genomic organization of Borna disease virus. Proc Natl Acad Sci USA 1994;91:4362-4366.
6. Cubitt B, De la Torre JC: Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present. J Virol 1994;68:1371-1381.
7. Schwemmle M, Salvatore M, Shi L, Richt J, Lee CH, Lipkin WI: Interactions of the borna disease virus P, N, and X proteins and their functional implications. J Biol Chem 1998;273:9007-9012.
8. Wehner T, Ruppert A, Herden C, Frese K, Becht H, Richt JA: Detection of a novel Borna disease virus-encoded 10 kDa protein in infected cells and tissues. J Gen Virol 1997;78:2459-2466.
9. Gonzalez-Dunia D, Cubitt B, Grasser FA, De la Torre JC: Characterization of Borna disease virus p56 protein, a surface glycoprotein involved in virus entry. J Virol 1997;71:3208-3218.
10. Schneider PA, Hatalski CG, Lewis AJ, Lipkin WI: Biochemical and functional analysis of the Borna disease virus G protein. J Virol 1997;71:331-336.
11. Kliche S, Briese T, Henschen AH, Stitz L, Lipkin WI: Characterization of a Borna disease virus glycoprotein, gp18. J Virol 1994;68:6918-6923.
12. Stoyloff R, Bode L, Borchers K, Ludwig H: Neutralization of borna disease virus depends upon terminal carbohydrate residues (alpha-Dman, beta-D-GlcNAc) of glycoproteins gp17 and gp94. Intervirology 1998;41:135-140.
13. Kraus I, Eickmann M, Kiermayer S, Scheffczik H, Fluess M, Richt JA, Garten W: Open reading frame III of borna disease virus encodes a nonglycosylated matrix protein. J Virol 2001;75:12098-12104.
14. Danner K, Heubeck D, Mayr A: In vitro studies on Borna disease. I. The use of cell cultures for the demonstration, titration and production of Borna virus. Arch Virol 1978;57:63-75.
15. Ludwig H, Furuya K, Bode L, Klein N, Durrwald R, Lee DS: Biology and neurobiology of Borna disease viruses (BDV), defined by antibodies, neutralizability and their pathogenic potential. Arch Virol Suppl 1993;7:111-133.
16. Cubitt B, Oldstone C, De la Torre JC: Sequence and genome organization of Borna disease virus. J Virol 1994;68:1382-1396.
17. Briese T, Lipkin WI, De la Torre JC: Molecular biology of Borna disease virus. Curr Top Microbiol Immunol 1995;190:1-16.
18. Hatalski CG, Kliche S, Stitz L, Lipkin WI: Neutralizing antibodies in Borna disease virus-infected rats. J Virol 1995;69:741-747.
19. Hatalski CG, Hickey WF, Lipkin WI: Humoral immunity in the central nervous system of Lewis rats infected with Borna disease virus. J Neuroimmunol 1998;90:128-136.
20. Stitz L, Noske K, Planz O, Furrer E, Lipkin WI, Bilzer T: A functional role for neutralizing antibodies in Borna disease: Influence on virus tropism outside the central nervous system. J Virol 1998;72:8884-8892.
21. Furrer E, Bilzer T, Stitz L, Planz O: Neutralizing antibodies in persistent borna disease virus infection: Prophylactic effect of gp94-specific monoclonal antibodies in preventing encephalitis. J Virol 2001;75:943-951.
22. Gonzalez-Dunia D, Cubitt B, De la Torre JC: Mechanism of Borna disease virus entry into cells. J Virol 1998;72:783-788.
23. Schneider PA, Kim R, Lipkin WI: Evidence for translation of the Borna disease virus G protein by leaky ribosomal scanning and ribosomal reinitiation. J Virol 1997;71:5614-5619.
24. Wagner RR: Rhabdovirus biology and infection: An overview; in Wagner RR (ed): The Rhabdoviruses. New York, Plenum, 1987, pp 25-68.
25. Morrison T, Portner A: Structure, function and intracellular processing of the glycoproteins of Paramyxoviridae; in Kingsbury DW (ed): The Paramyxoviruses. New York, Plenum, 1991, pp 347-382.
26. Richt JA, Furbringer T, Koch A, Pfeuffer I, Herden C, Bause-Niedrig I, Garten W: Processing of the Borna disease virus glycoprotein gp94 by the subtilisin-like endoprotease furin. J Virol 1998;72:4528-4533.
27. Furrer E, Bilzer T, Stitz L, Planz O: High-dose Borna disease virus infection induces a nucleoprotein-specific cytotoxic T-lymphocyte response and prevention of immunopathology. J Virol 2001;75:11700-11708.
28. Deschl U, Stitz L, Herzog S, Frese K, Rott R: Determination of immune cells and expression of major histocompatibility complex class II antigen in encephalitic lesions of experimental Borna disease. Acta Neuropathol (Berl) 1990;81:41-50.
29. Terry-Allison T, Montgomery RI, Whitbeck JC, Xu R, Cohen GH, Eisenberg RJ, Spear PG: HveA (herpesvirus entry mediator A), a coreceptor for herpes simplex virus entry, also participates in virus-induced cell fusion. J Virol 1998;72:5802-5810.
30. Castilla V, Mersich SE: Low-pH-induced fusion of Vero cells infected with Junin virus. Arch Virol 1996;141:1307-1317.
31. Butcher M, Raviprakash K, Ghosh HP: Acid pH-induced fusion of cells by herpes simplex virus glycoproteins gB and gD. J Biol Chem 1990;265:5862-5868.
32. Schlesinger MJ, Schlesinger S: Domains of virus glycoproteins. Adv Virus Res 1987;33:1-44.
33. Marsh M, Helenius A: Virus entry into animal cells. Adv Virus Res 1989;36:107-151.
34. White JM: Viral and cellular membrane fusion proteins. Annu Rev Physiol 1990;52:675-697.